algos

algos

An obsolete term for a painful disease-related spasm or crisis.
References in periodicals archive ?
Since these algos have numerous customization options, clients like CTAs, hedge funds, private and institutional traders can execute orders within their stated parameters extremely efficiently in a variety of market conditions.
Stock exchanges shall have a system to identify dysfunctional algos and take suitable measures including advising the member, to shut down such algos and remove and outstanding orders in the system that have emanated from such dysfunctional algos.
Algos Pharmaceutical Corporation (NASDAQ: ALGO) has announced additional data from its Phase III clinical trials for its lead product MorphiDex(tm).
With Hosted Algos, clients can use Pragma's high-performance algorithms with their executing brokers of choice, giving clients more control over their execution.
This combined offering will enable Destimoney to develop, test and deploy their algos seamlessly.
18 /PRNewswire/ -- Following a shift in its business model from developing proprietary pain therapy products to pure contract research, Algos Therapeutics has changed its name to Algos Preclinical Services.
Based in the San Francisco Bay area, Cara teamed with Algos last month and will be responsible for developing and expanding business in Western US/Canada, South America, Asia and Australia.
Algos Pharmaceutical Corporation (Nasdaq: ALGO) today reported financial results for the first quarter ended March 31, 2000.
NEW YORK -- EdgeTrade, agency broker and developer of algorithmic strategies and direct market access (DMA) software utilized by institutional buy-side and sell-side firms in North America and Europe, today announced the unveiling of Algos Plus, an outsourcing service that enables broker-dealers to private label EdgeTrade's algorithms.
23 /PRNewswire/ -- Algos Pharmaceutical Corporation (Nasdaq: ALGO) today announced that John Lyle, President and CEO of Algos, sold 224,100 shares of the Company's common stock and Frank Caruso, Ph.
The current quarter's issue looks at: Algos Pharmaceutical Co.
16 /PRNewswire/ -- Algos Pharmaceutical Corporation (Nasdaq: ALGO) today announced it met with the United States Food and Drug Administration (FDA) on December 13 relating to its New Drug Application (NDA) for MorphiDex(R), an NMDA enhanced opioid analgesic.